EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RD Lawrence lecture 2013. Stratified approaches to the management of diabetes



RD Lawrence lecture 2013. Stratified approaches to the management of diabetes



Diabetic Medicine 31(4): 393-398



A stratified approach to medicine aims to identify subgroups of patients who should be managed differently from others. Diabetes is a condition that offers considerable potential for stratification, in areas of drug response, complication risk and rate of progression amongst others. Approaches to stratification can be simple, using clinical phenotyping, or more complex involving genomic and other '-omic' technologies. In this review, I will highlight the utility of measuring endogenous insulin production to aid in diagnosis and appropriate treatment; outline key advances in monogenic diabetes where determining genetic aetiology can result in dramatic changes in treatment, and describe the developments in the field of pharmacogenetics in Type 2 diabetes.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333954

Download citation: RISBibTeXText

PMID: 24344913

DOI: 10.1111/dme.12391



Related references

Lawrence Lecture. The Emperor's new genes: 1993 RD Lawrence Lecture. Diabetic Medicine 11(1): 6-16, 1994

Lawrence Lecture. Hypoglycaemia and diabetes. Diabetic Medicine 3(6): 513-525, 1986

R.D. Lawrence Lecture 1995 Mrs Sprat's diabetes: some metabolic insights. Diabetic Medicine 13(7): 616-624, 1996

RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes. Diabetic Medicine, 2017

RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!. Diabetic Medicine 30(3): 260-266, 2013

RD Lawrence Lecture 2008: Targeting GLP-1 release as a potential strategy for the therapy of Type 2 diabetes. Diabetic Medicine 25(8): 889-894, 2008

Differing aspects of insulin resistance in diabetes complications: the shape of things to come. RD Lawrence lecture 2000. Diabetic Medicine 19(12): 973-977, 2002

Differing aspects of insulin resistance in diabetes complications: the shape of things to come. RD Lawrence Lecture 2000. Diabetic Medicine 19(12): 973-977, 2003

R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabetic Medicine 28(2): 141-147, 2011

Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet. Oncology 14(12): E524-E534, 2013

Diabetes mellitus--a global pandemic. Keynote lecture presented at the Wonca conference in Prague in June 2013. European Journal of General Practice 20(1): 65-68, 2014

Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013. Ophthalmic Genetics 35(4): 193-207, 2015

2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 34(4): 705-714, 2014

Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet. Oncology 14(12): E508-E523, 2013

Development and validation of the Diabetes Management Orientation Scale (DMOS): assessing culturally related approaches to diabetes self-management. Diabetes Research and Clinical Practice 86(1): 24-30, 2009